Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNMT1 | P26358 | 1/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.66 |
| ▸ | MAPT | P10636 | 3/20 | 0.66 |
| ▸ | MEN1 | O00255 | 2/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.66 |
| ▸ | RAB9A | P51151 | 2/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.66 |
| ▸ | CES1 | P23141 | 3/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16144669 | 0.96 | DNMT1 (0.68) | DNMT1ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL29358121 | 0.94 | DNMT1 (0.78) | DNMT1ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL29411157 | 0.94 | DNMT1 (0.78) | DNMT1ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL29612224 | 0.94 | DNMT1 (0.78) | DNMT1ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL183078 | 0.94 | DNMT1 (0.78) | DNMT1ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL9900718 | 0.93 | DNMT1 (0.70) | DNMT1ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL19230419 | 0.93 | DNMT1 (0.83) | DNMT1ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL12236188 | 0.91 | DNMT1 (0.67) | DNMT1ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL19230420 | 0.91 | DNMT1 (0.73) | DNMT1ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL16144677 | 0.91 | DNMT1 (0.80) | DNMT1ALDH1A1MAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2649082-B1 | NON-LINEAR ACENE DERIVATIVES AND THEIR USE AS ORGANIC SEMICONDUCTORS | MERCK PATENT GMBH (DE) | 2015-01-14 | — | — | EP | disclosed |
| EP-2649082-B1 | NON-LINEAR ACENE DERIVATIVES AND THEIR USE AS ORGANIC SEMICONDUCTORS | MERCK PATENT GMBH (DE) | 2015-01-14 | — | — | EP | disclosed |
| EP-2649082-A1 | NON-LINEAR ACENE DERIVATIVES AND THEIR USE AS ORGANIC SEMICONDUCTORS | Merck Patent GmbH (DE) | 2013-10-16 | — | — | EP | disclosed |
| US-20130248771-A1 | NON-LINEAR ACENE DERIVATIVES AND THEIR USE AS ORGANIC SEMICONDUCTORS | MERCK PATENT GMBH (DE) | 2013-09-26 | — | — | US | disclosed |
| US-20130248771-A1 | NON-LINEAR ACENE DERIVATIVES AND THEIR USE AS ORGANIC SEMICONDUCTORS | MERCK PATENT GMBH (DE) | 2013-09-26 | — | — | US | disclosed |
| US-20130248771-A1 | NON-LINEAR ACENE DERIVATIVES AND THEIR USE AS ORGANIC SEMICONDUCTORS | MERCK PATENT GMBH (DE) | 2013-09-26 | — | — | US | disclosed |
| WO-2012076092-A1 | NON-LINEAR ACENE DERIVATIVES AND THEIR USE AS ORGANIC SEMICONDUCTORS | MERCK PATENT GMBH (DE) | 2012-06-14 | — | — | WO | disclosed |
| WO-2012076092-A1 | NON-LINEAR ACENE DERIVATIVES AND THEIR USE AS ORGANIC SEMICONDUCTORS | MERCK PATENT GMBH (DE) | 2012-06-14 | — | — | WO | disclosed |
| US-20030082101-A1 | Accelerators for increasing the rate of formation of free radicals and reactive oxygen species | CAVALIER DISCOVERY | 2003-05-01 | — | — | US | disclosed |
| EP-0490862-B1 | Process for producing n-phosphonomethylglycine | MONSANTO CO (US) | 1996-01-24 | — | — | EP | disclosed |
| EP-0490862-A1 | Process for producing n-phosphonomethylglycine | MONSANTO COMPANY (US) | 1992-06-17 | — | — | EP | disclosed |
| US-5072033-A | N-phosphonomethyl iminodiacetic acid oxidized with peroxide in the presence of cobalt or vandadium salt and quinone or deriv ative | MONSANTO COMPANY (US) | 1991-12-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030082101-A1 | Accelerators for increasing the rate of formation of free radicals and reactive oxygen species | SOD1, SOD3, APEX1 | DNMT1 502/4885ALDH1A1 1216/4885MAPT 3245/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.